Suppr超能文献

中国推迟转基因抗虫水稻商业化的代价。

The Cost of Postponement of Bt Rice Commercialization in China.

作者信息

Jin Yan, Drabik Dus An, Heerink Nico, Wesseler Justus

机构信息

Wageningen University & Research, Wageningen, Netherlands.

出版信息

Front Plant Sci. 2019 Oct 8;10:1226. doi: 10.3389/fpls.2019.01226. eCollection 2019.

Abstract

To maintain self-sufficiency in rice production and national food security, the Chinese government strongly supports research that aims at increasing the productivity of rice cultivation. Rice with genetic material from Bacillus thuringiensis (Bt rice) is transgenic rice that can reduce lepidopteran pest damage and the use of insecticides. It was developed in the 1990s and earned biosafety certificates in 2009. However, because of political reasons, its commercialization in China has been postponed, and, to date, Bt rice is not grown in China. We assess the opportunity cost of postponement of Bt rice commercialization in China between the years 2009 and 2019 and consider the external costs of pesticide use and potential technology spill-overs of Bt rice. We estimate the cost of postponement of Bt rice over the analyzed period to be 12 billion United States (US) dollars per year.

摘要

为维持水稻生产的自给自足及国家粮食安全,中国政府大力支持旨在提高水稻种植产量的研究。含有苏云金芽孢杆菌(Bt水稻)遗传物质的水稻是一种转基因水稻,它能够减少鳞翅目害虫的危害并降低杀虫剂的使用量。该品种于20世纪90年代培育成功,并于2009年获得生物安全证书。然而,出于政治原因,其在中国的商业化进程被推迟,截至目前,中国尚未种植Bt水稻。我们评估了2009年至2019年间中国推迟Bt水稻商业化的机会成本,并考虑了农药使用的外部成本以及Bt水稻潜在的技术溢出效应。我们估计,在分析期内,推迟Bt水稻商业化每年造成的成本为120亿美元。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2591/6792301/3229085285e8/fpls-10-01226-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验